In what medical experts are calling a potential game-changer in oncology, Russia’s newly developed mRNA cancer vaccine, Enteromix, has demonstrated 100 percent efficacy and safety in clinical trials. If approved, the treatment could revolutionize cancer care and potentially save millions of lives worldwide. Developed by the National Medical Research Radiology Centre in partnership with the
Don't miss out on breaking stories and in-depth articles.
